Cefepime-induced neurotoxicity

Cefepime-induced neurotoxicity

We present a case of severe cefepime-induced neurotoxicity following acute kidney injury in a patient with a fracture-related infection. Despite stopping cefepime, the patient required intubation, ventilation, multiple antiepileptic drugs for seizure control, and haemodialysis. Contribution: Cefepi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jessica Taylor, Hannah M. Gunter, Karen Cohen
Format:	Article
Language:	English
Published:	AOSIS 2025-04-01
Series:	Southern African Journal of Infectious Diseases
Subjects:	cefepime neurotoxicity cefepime-induced neurotoxicity adverse drug reaction encephalopathy
Online Access:	https://sajid.co.za/index.php/sajid/article/view/704
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Straight to the Dome - Cefepime Induced Neurotoxicity
by: Hannah Starbuck, et al.
Published: (2025-06-01)

Risk of Potentially Neurotoxic Exposure in Infants Under High-Dose Cefepime Treatment—A Pharmacometric Simulation Study
by: Verena Gotta, et al.
Published: (2025-04-01)

Encefalopatia induzida por cefepime: achados clínicos e eletroencefalográficos em sete pacientes Cefepime-induced encephalopathy: clinical and electroencephalographic features in seven patients
by: José Augusto Bragatti, et al.
Published: (2005-03-01)

Cefepime Induced Encephalopathy in a Non-dialysis Dependent Chronic Kidney Disease Patient: A Case Report
by: Giritharan Muniandy, et al.
Published: (2023-03-01)

Development of cefepime‐induced encephalopathy in a patient with depression and rectal cancer: A case report
by: Junji Yamaguchi, et al.
Published: (2025-03-01)

Intraventricular Administration of Cefepime for the Treatment of Meningitis due to Pseudomonas aeruginosa
by: Sameer Abdul Samad1*, et al.
Published: (2023-03-01)

Impact of Extracorporeal Membrane Oxygenation (ECMO) on Serum Concentrations of Cefepime
by: Christopher J. Destache, et al.
Published: (2024-10-01)

Comparative Analysis of the Effectiveness of Generic and Brand-Name Cefepime: A Multicenter Retrospective Cohort Study
by: Chih-Huang Li, et al.
Published: (2025-01-01)

The Effect of Cefepime/Fluorothiazinone Compared with Cefepime/Placebo on Clinical Cure and Microbiological Eradication in Patients with Complicated Urinary Tract Infections: A Prospective Randomized Clinical Trial
by: V. B. Beloborodov, et al.
Published: (2025-02-01)

Real-world efficacy and safety of cefepime for pediatric community-acquired pneumonia: a propensity score-matched study
by: Changxin Liu, et al.
Published: (2025-06-01)

Comparison of clinical outcomes of treatment with cefepime monotherapy vs. amikacin-ceftriaxone combination in children with chemotherapy-induced fever and neutropenia
by: Zahra Ghelichkhan, et al.
Published: (2025-04-01)

Drug-Induced Myoclonus: A Systematic Review
by: Jamir Pitton Rissardo, et al.
Published: (2025-01-01)

<i>In vitro</i> activity of cefepime / sulbactam and biapenem against Enterobacterales and <i>Pseudomonas aeruginosa</i> isolated from blood culture from patients with hematological diseases: results of a multicenter study
by: G. A. Klyasova, et al.
Published: (2023-05-01)

The problem of neurotoxicity of drugs in the treatment of tuberculosis patients
by: G. N. Mozhokina, et al.
Published: (2020-11-01)

Specific Manifestations of Neurotoxicity of Some Drug Combinations for Treatment of Drug Resistant Tuberculosis from the Perspective of Experimental Studies
by: G. N. Mozhokina, et al.
Published: (2023-01-01)

Pediatric Opioid-Use-Associated Neurotoxicity with Cerebellar Edema: A Case of POUNCE Syndrome Following Vein of Galen Aneurysm Treatment
by: Maxime Goldfinger
Published: (2024-11-01)

Development of criteria for interpretation and quality assessment of the results of susceptibility testing of Enterobacterales and Pseudomonas aeruginosa to cefepime-sulbactam
by: Edelstein M.V., et al.
Published: (2024-12-01)

Tackling the unyielding: testing two novel approaches against NDM-producing Enterobacterales and Pseudomonas aeruginosa isolates collected in India
by: Yamuna Devi Bakthavatchalam, et al.
Published: (2025-01-01)

Neurotoxic Side Effects of Antimicrobial and Anti-Tuberculosis Drugs
by: G. N. Mozhokina, et al.
Published: (2020-08-01)

Risk Assessment of Linezolid-Associated Neurological Adverse Drug Reactions Based on the Food and Drug Administration Adverse Event Reporting System Database
by: Yin J, et al.
Published: (2025-05-01)

Possibilities of Using Nootropic Drugs to Reduce Neurotoxic Reactions Caused by Anti-tuberculosis Drugs in Experimental Conditions
by: G. N. Mozhokina, et al.
Published: (2024-07-01)

β-Lactam/β-Lactamase Inhibitor Combination Antibiotics Under Development
by: Angeliki Katsarou, et al.
Published: (2025-02-01)

Effects of Anti-Pseudomonal Agents, Individually and in Combination, With or Without Clarithromycin, on Growth and Biofilm Formation by Antibiotic-Susceptible and -Resistant Strains of <i>Pseudomonas aeruginosa,</i> and the Impact of Exposure to Cigarette Smoke Condensate
by: Moloko C. Cholo, et al.
Published: (2025-03-01)

Arsenic-Induced Neurotoxicity: A Study on the Brain–Behaviour Circuit
by: Chayan Munshi, et al.
Published: (2024-04-01)

Delayed Onset of Linezolid-induced Peripheral Neuropathy: A Case Report and Review with Symptom of Atypical Timeframes
by: Swapnil N Deshmukh, et al.
Published: (2025-05-01)

Colistin induced neurotoxicity with bulbar palsy. A case report and literature review
by: Mohamed Kamal Mansour, et al.
Published: (2024-01-01)

Investigation of the thiol-disulfide system state of rats with encephalopathy caused by the effect of antituberculous drugs
by: A. V. Levich, et al.
Published: (2019-12-01)

Valacyclovir-induced neurotoxicity and nephrotoxicity in an elderly patient with a history of nephrectomy: a case report
by: Sondos Badran, et al.
Published: (2025-05-01)

A developmental neurotoxicity adverse outcome pathway (DNT‐AOP) with voltage gate sodium channel (VGSC) inhibition as a molecular initiating event (MiE)
by: European Food Safety Authority (EFSA), et al.
Published: (2024-08-01)

Nephrotoxicity of New Antibiotics: A Systematic Review
by: Panagiotis Stathopoulos, et al.
Published: (2025-07-01)

Surface energetics of antibiofilm property of dental material added with green synthesized copper nanoparticles
by: Haris Saddique, et al.
Published: (2025-05-01)

Polystyrene Nanomicroplastics Aggravate Ammonia-Induced Neurotoxic Effects in Zebrafish Embryos
by: Dan Xing, et al.
Published: (2024-11-01)

Cefepime versus carbapenem for treating complicated urinary tract infection caused by cefoxitin-nonsusceptible ESCPM organisms: a multicenter, real-world study
by: Liang Chen, et al.
Published: (2025-03-01)

Adverse outcome pathway for the neurotoxicity of per- and polyfluoroalkyl substances: A systematic review
by: Shenpan Li, et al.
Published: (2024-12-01)

Fucoxanthin and its metabolite fucoxanthinol alleviate paraquat-induced oxidative damage and neurotoxicity in differentiated human neuroblastoma cells
by: Ekramy M. Elmorsy, et al.
Published: (2025-12-01)

Acute exposure of perchlorate on zebrafish larvae: Neurotoxicity during development
by: Xiaoran Xue, et al.
Published: (2025-04-01)

Deciphering the Neurotoxic Effects of <i>Karenia selliformis</i>
by: Ambbar Aballay-González, et al.
Published: (2025-02-01)

Perineural dexamethasone: neurotoxicity or neuroprotection? A systematic review of preclinical evidence
by: Alessandro De Cassai, et al.
Published: (2025-08-01)

Identification of potential drug-induced neuralgia signals through disproportionality analysis of the FAERS database
by: Yating An, et al.
Published: (2025-07-01)

Mechanisms of Neurotoxicity of Organophosphate Pesticides and Their Relation to Neurological Disorders
by: Chen Y, et al.
Published: (2024-11-01)